STREPTOZOTOTSIN ORQALI KELIB CHIQQAN QANDLI DIABETDA KALAMUSH AVLODLARI BUYRAKLARNING MORFOLOGIK O‘ZGARISHLARI

##article.authors##

  • TILYABOV Ikrom
  • USMANOV Ravshan

##article.subject##:

morfologiya, morometriya, buyrak, koptokcha, giperglikemik nefropatiyalar, atrofiya, skleroz, streptotsiazinli qandli diabet.

##article.abstract##

 Bolalarda,  odatda,  Qandi diabet(QD)ning  1-turi,  ko‘proq  2-turi  uchramoqda. Rivojlangan  giperglikemik  nefropatiyalar  (GN),  masalan,  nefronda  filtratsiya tezligi  (NFT)  yo‘qolishi,  balog‘at  yoshiga  qadar  sodir  bo‘lmasa -da,  buyrak biopsiyalari  1-turdagi  QD  boshlanganidan  keyin  1,5-5  yil  ichida  GN  tarkibiy o‘zgarishlarini  ko‘rsatadi.  GNning  eng  erta  klinik  belgisi,  masalan,  siydikda albumin ajralishining ko‘payishi, odatda bolalik va o‘smirlik davrida paydo bo‘ladi va  erta  GNni  aniqlash  va  davolash  uchun  muhim  imkoniyatdir.  1-turdagi  diabet masalasida olib borilgan tadqiqotlar shuni ko‘rsatdiki, GN erta o‘lim xavfi yuqori bo‘lgan  diabet  bilan  og‘rigan  odamlarning  bir  qismiga  xos,  bu  GNni  aniqlash, oldini  olish  va  davolashga  etiborni  kuchaytiradi.  Dastlabki  tadqiqotlar  shuni ko‘rsatadiki,  yoshlarda  boshlangan  2-turdagi  QD  xavf  omillarining  tarqalishi yuqoriligi  bilan  bog‘liq.  Yoshlarda  boshlangan  2-turdagi  QDda  GN  uchun  xavf omillarini,  asosiy  mexanizmlarini  va  davolash  variantlarni  chuqurroq  tushunib olish borasida ilmiy tadqiqotlarni olib borishga yordam beradi.

Библиографические ссылки

Pettitt DJ, Talton J, Dabelea D, Divers J, Imperatore G, Lawrence JM, Liese AD, Linder B, Mayer-Davis EJ, Pihoker C, Saidah SH, Standiford DA, Hamman RF for SfDiYSG. Prevalence of diabetes in US youth in 2009: looking for diabetes in youth. Caring for diabetes. 2014;37:402–408.

Imperatore G, Boyle JP, Thompson TJ, Case D, Dabelea D, Hamman RF, Lawrence JM, Liese AD, Liu LL, Mayer-Davis EJ, Rodriguez BL, Standiford D. Predictors of type 1 and type 2 burden. diabetes. . The US population under 20 years of age to 2050: dynamic modeling of incidence, mortality, and population growth. Caring for diabetes. 2012;35:2515–2520.

Groop PH, Thomas MC, Moran JL, Waden J, Thorn LM, Makinen VP, Rosengard-Barlund M, Saraheimo M, Hietala K, Heikkila O, Forsblom C, FinnDiane Study G. Predictors of presence and severity of chronic kidney disease. doers does. All-cause mortality in type 1 diabetes. Diabetes. 2009;58:1651–1658. 4. Orchard TJ, Secrest AM, Miller RG, Costacou T. In the absence of kidney disease: 20-year risk of death in type 1 diabetes compared with the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes. 2010;53:2312–2319.

Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, de Boer IH. It increases the risk of death from kidney disease and type 2 diabetes. J Am Soc Nephrol. 2013;24:302–308.

Amin R, Widmer B, Prevost AT, Schwarze P, Cooper J, Edge J, Marcovecchio L, Neil A, Dalton RN, Dunger DB. Microalbuminuria and risk of progression to macroalbuminuria in a cohort with childhood type 1 diabetes: a prospective observational study. BMJ (Journal of Clinical Research) 2008; 336: 697-701.

Katz A, Caramori ML, Sisson-Ross S, Groppoli T, Basgen JM, Mauer M. Increased cortical interstitial cellular component precedes interstitial fibrosis in type 1 diabetic patients. Kidney Int. 2002;61:2058–2066.

Sources of funding: The work did not receive any specific funding.

Conflict of interest: The authors declare no explicit or potential conflicts of interest associated with the publication of this article.

Contribution of the authors:

Tilyabov Ikram - Basic doctoral student Tashkent Medical Academy, ORCID 0009-0005-1365-9474, tilyabovi@gmail.com— ideological concept of the work, writing the text; editing the article;

Usmanov Ravshan Doctor of Medical science, professorTashkent Medical Academy ORCID 0000-0002-2459-9084 r.usmanov.54@mail.ru— collection and analysis of literature sources, writing the text.

Avtorlar to’g’risida ma’lumot:

Tilyabov Ikrom Tayanch doktorant Toshkent Tibbiyot Akademiyasi

tilyabovi@gmail.com ORCID 0009-0005-1365-9474 – maqolani matnini yozish; maqolani tahrirlash;

Usmanov Ravshan tibbiyot fanlari doktori, professor, Toshkent Tibbiyot Akademiyasi r.usmanov.54@mail.ru,ORCID: 0000-0002-2459-9084 adabiyot manbalarini to‘plash va tahlil qilish, matn yozish.

Загрузки

##submissions.published##

2024-06-15